A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Cora N. Sternberg(Carlo Forlanini Hospital), Robert E. Hawkins(University of Manchester), John Wagstaff(Singleton Hospital), Pamela Salman(Fundación Arturo López Pérez), Jozef Mardiak, Carlos H. Barrios(Pontifícia Universidade Católica do Rio Grande do Sul), Juan José Zarbá(Centro Científico Tecnológico - Tucumán), Oleg Gladkov(Chelyabinsk Regional Clinical Oncology Center), Eunsik Lee(Seoul National University), Cezary Szczylik(Wojskowy Instytut Medycyny Lotniczej), Lauren McCann(GlaxoSmithKline (United States)), Stephen D. Rubin(GlaxoSmithKline (United States)), Mei Chen(GlaxoSmithKline (United States)), Ian D. Davis(Ludwig Cancer Research)
Cited by 445
Abstract
Related Papers
No related papers found
Powered by citation graph analysis